BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 10822340)

  • 1. Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function.
    Willenberg HS; Bornstein SR; Hiroi N; Päth G; Goretzki PE; Scherbaum WA; Chrousos GP
    Mol Psychiatry; 2000 Mar; 5(2):137-41. PubMed ID: 10822340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific CRH antagonist attenuates ACTH-stimulated cortisol secretion in ovine adrenocortical cells.
    Valego NK; Rose JC
    Reprod Sci; 2010 May; 17(5):477-86. PubMed ID: 20220106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation.
    Bornstein SR; Webster EL; Torpy DJ; Richman SJ; Mitsiades N; Igel M; Lewis DB; Rice KC; Joost HG; Tsokos M; Chrousos GP
    Endocrinology; 1998 Apr; 139(4):1546-55. PubMed ID: 9528933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing hormone receptor expression on normal and tumorous human adrenocortical cells.
    Willenberg HS; Haase M; Papewalis C; Schott M; Scherbaum WA; Bornstein SR
    Neuroendocrinology; 2005; 82(5-6):274-81. PubMed ID: 16721033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antalarmin, a novel corticotropin-releasing hormone antagonist, on the dynamic function of the preterm ovine fetal hypothalamo-pituitary-adrenal axis.
    Young IR; Chan EC; Smith R; Chrousos GP; Veldhuis JD; Canny BJ
    Neuroendocrinology; 2002 Jul; 76(1):47-54. PubMed ID: 12097816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys.
    Broadbear JH; Winger G; Rivier JE; Rice KC; Woods JH
    Neuropsychopharmacology; 2004 Jun; 29(6):1112-21. PubMed ID: 14997174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.
    Webster EL; Lewis DB; Torpy DJ; Zachman EK; Rice KC; Chrousos GP
    Endocrinology; 1996 Dec; 137(12):5747-50. PubMed ID: 8940412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.
    Dinopoulou V; Partsinevelos GA; Mavrogianni D; Anagnostou E; Drakakis P; Makrigiannakis A; Chrousos GP; Loutradis D
    Endocrinology; 2013 Jan; 154(1):222-31. PubMed ID: 23211705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of adrenocorticotrophic hormone receptor by corticotropin-releasing hormone in human fetal adrenal definitive/transitional zone cells.
    Rehman KS; Sirianni R; Parker CR; Rainey WE; Carr BR
    Reprod Sci; 2007 Sep; 14(6):578-87. PubMed ID: 17959886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress.
    Deak T; Nguyen KT; Ehrlich AL; Watkins LR; Spencer RL; Maier SF; Licinio J; Wong ML; Chrousos GP; Webster E; Gold PW
    Endocrinology; 1999 Jan; 140(1):79-86. PubMed ID: 9886810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antalarmin, a putative CRH-RI antagonist, has transient reinforcing effects in rhesus monkeys.
    Broadbear JH; Winger G; Rice KC; Woods JH
    Psychopharmacology (Berl); 2002 Nov; 164(3):268-76. PubMed ID: 12424550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress.
    Wong ML; Webster EL; Spokes H; Phu P; Ehrhart-Bornstein M; Bornstein S; Park CS; Rice KC; Chrousos GP; Licinio J; Gold PW
    Life Sci; 1999; 65(4):PL53-8. PubMed ID: 10421433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells.
    Smith R; Mesiano S; Chan EC; Brown S; Jaffe RB
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2916-20. PubMed ID: 9709969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation.
    Webster EL; Barrientos RM; Contoreggi C; Isaac MG; Ligier S; Gabry KE; Chrousos GP; McCarthy EF; Rice KC; Gold PW; Sternberg EM
    J Rheumatol; 2002 Jun; 29(6):1252-61. PubMed ID: 12064844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral, adrenal, and sympathetic responses to long-term administration of an oral corticotropin-releasing hormone receptor antagonist in a primate stress paradigm.
    Ayala AR; Pushkas J; Higley JD; Ronsaville D; Gold PW; Chrousos GP; Pacak K; Calis KA; Gerald M; Lindell S; Rice KC; Cizza G
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5729-37. PubMed ID: 15531536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hypophysectomy on corticotropin-releasing hormone and adrenocorticotropin immunoreactivities in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Markowska A; Nussdorfer GG
    Mol Cell Neurosci; 1994 Aug; 5(4):345-9. PubMed ID: 7804604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of corticotropin-releasing hormone type 1 receptor in paraventricular nucleus after acute stress.
    Imaki T; Katsumata H; Miyata M; Naruse M; Imaki J; Minami S
    Neuroendocrinology; 2001 May; 73(5):293-301. PubMed ID: 11399902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors.
    Cantarella G; Lempereur L; Lombardo G; Chiarenza A; Pafumi C; Zappalà G; Bernardini R
    Br J Pharmacol; 2001 Oct; 134(4):837-44. PubMed ID: 11606324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol.
    Ito N; Ito T; Kromminga A; Bettermann A; Takigawa M; Kees F; Straub RH; Paus R
    FASEB J; 2005 Aug; 19(10):1332-4. PubMed ID: 15946990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.